Materials and Methods: The current review was conducted on studies published from January 1, 2000 to November 15, 2014 through Scopus, Web of sciences, Google scholar, Embase, and two MEDLINE database engines: PubMed and Ovid. Different combinations of the following keywords "Helicobacter pylori, H. pylori, atherosclerotic plaques, atherosclerotic lesion, and atherosclerotic vascular disease" were used. Results: Four good-quality investigations met our inclusion criteria. The pooled odd ratio (OR) for the presence of H. pylori in the atherosclerotic plaques of patients with atherosclerotic vascular disease in a fixed model was 4.65 (95% CI=1.99-10.85, p=0.001). According to the chi-square test, there was a significant heterogeneity (67.6%) among studies (p=0.026). In a random effects method, the pooled OR was 5.98 (95% CI=0.69-51.99, p=0.10). Conclusion: According to the results of this meta-analysis, H. pylori is not a significant risk factor for atherosclerotic vascular disease. However, evidence on this effect is inadequate. Hence, more original studies are still needed.